Clinical Trials on Cervical Cancer Stage in Japan
Total 1184 results
-
AbbViePfizerActive, not recruitingCancer | Non-small Cell Lung Cancer (NSCLC)United States, Israel, Japan, Korea, Republic of, Spain, Taiwan
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
AbbVieTerminatedCancer | Breast CancerUnited States, Germany, Japan, Puerto Rico
-
Millennium Pharmaceuticals, Inc.CompletedColorectal Cancer | Esophageal Neoplasms | Metastatic Pancreatic Cancer | Carcinoma, Non-small-cell LungUnited States, Japan
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Boston Scientific CorporationCompletedPancreatic CancerUnited States, Korea, Republic of, Belgium, Italy, Japan, Canada
-
SanofiRegeneron PharmaceuticalsCompletedColorectal Cancer MetastaticTaiwan, China, Hong Kong, Japan, Singapore
-
Kuhnil Pharmaceutical Co., Ltd.Daiichi Sankyo Co., Ltd.TerminatedGastric Cancer | Gastroesophageal Junction CancerTaiwan, Japan, Korea, Republic of
-
Toray Industries, IncRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Japan
-
Mie UniversityCompletedColorectal Cancer | Lung MetastasisJapan
-
Novartis PharmaceuticalsRecruitingMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersJapan, Italy, Spain, Singapore, Belgium, Germany, Korea, Republic of, Sweden, Taiwan, France, Israel, Norway, United States
-
National Cancer Center Hospital EastJapan Agency for Medical Research and Development; Japan Clinical Oncology...Recruiting
-
AstraZenecaCompletedAdvanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast CancerCanada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Ductal Adenocarcinoma | Esophageal Adenocarcinoma | Gastro-esophageal Junction CancerKorea, Republic of, United States, Japan, Taiwan, China, United Kingdom, Netherlands
-
PfizerTerminatedMetastatic Colorectal CancerKorea, Republic of, United States, Japan, Spain
-
PfizerRecruitingNSCLC | Non-Small-Cell Lung CancerSpain, China, Taiwan, France, Singapore, Japan, United States
-
Novartis PharmaceuticalsCompletedCancerFrance, Belgium, Netherlands, United States, Spain, Japan, United Kingdom, Italy
-
AstraZenecaCompleted
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
Novartis PharmaceuticalsTerminatedMelanoma | Head and Neck Cancer | Pancreatic Cancer | Urothelial Cancer | NSCLC, Non Small Cell Lung Cancer | RCC, Renal Cell Cancer | DLBCL, Diffused Large B Cell Lymphoma | MSS, Microsatellite Stable Colon Cancer | TNBC, Triple Negative Breast Cancer | mCRPC, Metastatic Castration Resistant Prostate...Belgium, Italy, Taiwan, Germany, Spain, United States, Argentina, Australia, Austria, Czechia, France, Japan, Netherlands, Switzerland, Singapore
-
AmgenAvailableSmall Cell Lung CancerUnited States, Brazil, Japan
-
AmgenActive, not recruitingSmall Cell Lung CancerUnited States, Belgium, Austria, Singapore, Taiwan, Japan
-
Seagen Inc.Active, not recruitingUrologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Carcinoma, Non-Small-Cell Lung | Biliary Tract Neoplasms | HER2 Mutations Breast NeoplasmsUnited States, United Kingdom, Spain, Korea, Republic of, Italy, Belgium, Germany, Japan, Netherlands, Poland
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
PfizerCompletedALK-positive Non-small-cell Lung CancerJapan
-
Astellas Pharma IncPfizerCompletedCastration-resistant Prostate CancerJapan
-
GlaxoSmithKlineCompletedNeoplasms, Gastrointestinal TractTaiwan, Korea, Republic of, China, Japan
-
PfizerJapan Breast Cancer Research Group (JBCRG)Completed
-
PfizerActive, not recruitingBreast CancerJapan, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
TakedaActive, not recruitingNon-Small Cell Lung CancerJapan
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal JunctionGermany, United States, Spain, United Kingdom, France, Japan
-
European Organisation for Research and Treatment...Japan Clinical Oncology Group; European Society of Surgical OncologyCompletedColorectal Cancer | Colon Cancer Liver Metastasis | Malignant Neoplasm of Rectum Metastatic to LiverFrance, Japan, Belgium, United States, Austria
-
Taiho Oncology, Inc.CompletedAdvanced or Metastatic Non-small Cell Lung CancerUnited States, France, Poland, Spain, Italy, Japan
-
Bristol-Myers SquibbCompleted
-
Daiichi Sankyo, Inc.CompletedLiver Neoplasms | Advanced Hepatocellular Carcinoma | Liver Cancer | Hepatic CancerKorea, Republic of, Taiwan, United States, Japan
-
ppharmaand GmbHBristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaboratorsActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete ResponseUnited States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerChina, Taiwan, Belgium, Netherlands, Spain, Germany, Singapore, Italy, Japan, Australia, Israel, Korea, Republic of, Thailand, France
-
MedImmune LLCTerminatedNon-small Cell Lung CancerUnited States, Canada, Japan, Poland, Germany, Hungary, France
-
Althaia Xarxa Assistencial Universitària de ManresaHospital Clinic of Barcelona; University of North Carolina, Chapel Hill; Germans... and other collaboratorsCompletedColorectal Cancer | Colorectal PolypSpain, United States, Japan
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain, Taiwan, Japan, United States, France, Germany, Korea, Republic of, Malaysia
-
PfizerOxOnc Development LPCompletedNon Small Cell Lung Cancer | Crizotinib | ROS1 Proto OncogeneKorea, Republic of, China, Taiwan, Japan
-
National Hospital Organization Nagoya Medical CenterRecruitingAcute Lymphoblastic Leukemia | Down Syndrome | Childhood CancerTaiwan, Thailand, Hong Kong, Singapore, Malaysia, Japan
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
Haihe Biopharma Co., Ltd.RecruitingOvarian Cancer | Recurrent CancerChina, Japan